Apple Health (Medicaid) Provider Alert
Attention providers
What changed? The Health Care Authority (HCA) has updated its COVID-19 therapies policy with information regarding a new COVID-19 monoclonal antibody.
New COVID-19 monoclonal antibodies Retroactive for dates of service on and after February 24, 2022, providers may bill HCA for the following monoclonal antibody treatment:
HCPCS code Short description Q0221 Tixagev and cilgay, 600mg
See Therapies for COVID-19, under COVID-19 resources, Testing and Treatment for more information regarding the policy and procedure codes involved.
COVID-19 Fee Schedule HCA revised the COVID-19 Fee Schedule. See HCA’s Provider billing guides and fee schedules, under COVID-19.
|